VersaTrial Announces Formation of Advisory Board and Appointment of Global Pharma Executive Jackie Kent

WILTON, Connecticut, May 17, 2023 – VersaTrial, the clinical research site enablement and engagement platform, is proud to announce the creation of the VersaTrial Advisory Board and the appointment of Jackie Kent as its first member. Kent, a seasoned global pharma executive, board director, and advisor, brings her passion for patient access to clinical trials, comprehensive knowledge of healthcare technology, and experience in clinical trial design and execution to the newly formed board.

"I am thrilled to join the VersaTrial Advisory Board," said Kent. "This company is at the forefront of innovation, addressing the challenges faced by clinical research sites in a rapidly evolving technological landscape. I am excited to be part of this journey as we collaborate to streamline site processes, enhance communication and collaboration between sites, their Sponsors, and CROs, and ultimately, expedite the delivery of life-saving therapies to market more quickly and safely."

Kent has an impressive track record of developing transformative capabilities, building collaborative relationships, and launching new IT platforms and strategies in the healthcare industry. Alongside her recent advisory position at VersaTrial, she is also actively involved in numerous life science-oriented technology and advocacy organizations. These include the Board of Directors for Circuit Clinical and Curavit, as well as advisory roles with the Society for Clinical Research Sites (SCRS), TruTag Technologies, Lazarex Cancer Foundation, Tigerlily Foundation, and Saama.

Mike Wenger, founder and CEO of VersaTrial, also shared his excitement about Kent’s appointment: "We are honored to have Jackie join us on our mission to improve clinical trial speed, quality, and stakeholder collaboration. Her wealth of knowledge and experience in the healthcare industry makes her the perfect addition to our Advisory Board. We are confident that with her guidance and expertise, VersaTrial will continue to break new ground in the field of clinical research site enablement and engagement."

About VersaTrial

VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at https://www.versatrial.io